Circulating HPV DNA as a Marker for Early Detection of Relapse in Patients with Cervical Cancer

PURPOSE: Almost all cervical cancers are caused by human papillomavirus (HPV) and patients with advanced stage are at high risk for relapse. Circulating HPV DNA (HPV ctDNA) may serve as a residual tumor marker at the end of chemoradiation or to predict relapse during the follow-up period. EXPERIMENT...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeannot, Emmanuelle, Latouche, Aurélien, Bonneau, Claire, Calméjane, Marie-Ange, Beaufort, Corine, Ruigrok-Ritstier, Kirsten, Bataillon, Guillaume, Larbi Chérif, Linda, Dupain, Célia, Lecerf, Charlotte, Popovic, Marina, de la Rochefordière, Anne, Lecuru, Fabrice, Fourchotte, Virginie, Jordanova, Ekaterina S., von der Leyen, Heiko, Tran-Perennou, Carine, Legrier, Marie-Emmanuelle, Dureau, Sylvain, Raizonville, Laurence, Bello Roufai, Diana, Le Tourneau, Christophe, Bièche, Ivan, Rouzier, Roman, Berns, Els M.J.J., Kamal, Maud, Scholl, Suzy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2021
Materias:
Precision Medicine and Imaging
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401545/
https://www.ncbi.nlm.nih.gov/pubmed/34210686
http://dx.doi.org/10.1158/1078-0432.CCR-21-0625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401545/
https://www.ncbi.nlm.nih.gov/pubmed/34210686
http://dx.doi.org/10.1158/1078-0432.CCR-21-0625

Ejemplares similares